» Download Public Reports
24 reports
- Company report
- January 2012
- 2 pages
... Small cap research unit, way up from the current trading price of $1.42. According to zacks analyst, grant zeng, cfa, the clinical stage company is at the forefront of targeting cancer stem cells ...
February 2012
... And made open source, discourages any company that wants to commercialise stem cell research from carrying out its activities in the uk.The medical research council has been lobbied extensively on this ...
December 2012
... therapy Ensuring timely delivery of pipeline timely delivery is a core component of our strategy. As one of the leading companies in the field of gene therapy and immunotherapy, we work closely ...
December 2011
... With a batch size of one dose Manufacturing design considerations to meet cell therapy quality objectives principles of design controls that have been integral to the development of medical devices for many ...
January 2012
... Secretion, even when added up to an hour after the addition of escherichia coli o111:b4 lps to the human macrophage/monocyte-like thp-1 cell line. In contrast, bac2a demonstrated no significant antiendotoxin ...
May 2012
... In infrastructure and the provision of support for companies has created a vibrant commercial supply chain with stem cell product and service companies working alongside global life science corporations ...
February 2013
... Of regenerative medicine and cell therapies Support for the development of enabling platform tools and technologies. Proposals to address development issues such as preclinical; formulation and delivery ...
November 2012
... Actuaries.Org.Uk cells, chemicals (drugs) or biologics cell therapies may function transiently to deliver signals that Stimulate a patients own stem cell-based repair system and/or Exert an anti ...
March 2013
... therapies in uk clinical trial and clinical use value investible propositions created leading to cell therapy companies that succeed and stay in the uk attractiveness demonstrating that the uk ...
April 2012
... Cell depletion significantly reduced antibody production. Intracellular cytokine staining showed that t cells are a major source of ifn-h9253 and il-10. Recombinant ply and, to a lesser extent, recombinant cbp ...